By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Prima Biomed 

Unit 7, 79 - 83 High Street

Melbourne  Victoria  3101  Australia
Phone: 61-3-9854-5700 Fax: 61-3-9854-5777


SEARCH JOBS


Industry
Biotechnology






Company News
Prima Biomed (PRR.AX) Release: LAG-3Ig (IMP321) Demonstrates Positive Safety And Efficacy Qualities In Breast Cancer Clinical Trial 6/5/2017 2:08:09 PM
Prima Biomed (PRR.AX) Announces Formation Of Clinical Advisory Board 6/1/2017 12:42:33 PM
Data From Prima Biomed (PRR.AX) AIPAC Clinical Trial To Be Presented At 2017 ASCO Conference 5/18/2017 10:57:43 AM
Prima Biomed (PRR.AX) Receives Approval For Third Cohort Of Phase I Melanoma Trial 4/20/2017 1:24:36 PM
Prima Biomed (PRR.AX) Receives Approval For Third Cohort Of Phase I Melanoma Trial 4/19/2017 8:53:58 AM
Prima Biomed (PRR.AX) Receives A$492,144 Tax Refund From Australian Government 4/12/2017 10:35:29 AM
Prima Biomed (PRR.AX) Completes Recruitment For Second Patient Cohort In Melanoma Trial And Will Present At ICI Conference In Boston 3/15/2017 12:04:30 PM
Prima Biomed (PRR.AX) Release: U.S.A. Patent Grants For IMP321 In Cancer 3/1/2017 11:43:29 AM
Prima Biomed (PRR.AX) Receives ~A$860,000 Tax Credit Payment From French Government 2/14/2017 11:36:47 AM
Prima Biomed (PRR.AX) Release: Company Commences Randomised Phase IIb Clinical Trial For IMP321 In Breast Cancer 1/20/2017 11:40:07 AM
12345678910...
//-->